Novel combination therapy offers promising results for treatment-refractory hepatoblastoma
Health Briefs
Related Stories
Health Briefs
Oct 07, 2025
FDA grants Breakthrough Therapy Designation to Angelman Syndrome treatment
Health Briefs
Oct 01, 2025
Dr. Mustafa Sahin gives Cain Labs' Inaugural John Swann Lecture in Epilepsy Series September 29, ...
73601
Health Briefs
Article